COMMUNIQUÉS West-GlobeNewswire

TLC to Present High-Scoring Scientific Abstracts on Acute Pain through Moderated Sessions at ASRA Spring 2019
25/03/2019
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 25, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of [...]
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Vital Therapies Stockholders Vote “FOR” the Proposed Business Transaction With Immunic AG and All the Related Proposals
25/03/2019
SAN DIEGO, March 25, 2019 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (VTL) announced today that Institutional Shareholder Services Inc. (ISS) and Glass, Lewis & Co., LLC (Glass Lewis) have both recommended that Vital [...]
Aino Health AB (publ): Aino Health hosts a seminar on value-based leadership
25/03/2019
25 th March, 2019 Aino Health is hosting the INSEAD seminar "Value-Based Leadership and Business as a Force for Good" on 27 March. The seminar will explore "Fair Process Leadership," an approach to leadership that [...]
Finns choose a domestic nicotine-free product as their preferred smoking intervention method
25/03/2019
Biohit Oyj and Sanoma Media invited 40 volunteers to try and quit smoking by using Acetium® lozenge and asked for feedback on their experience of using this alternative method. They received encouraging and positive [...]
Philips expands its radiology solutions offering with advanced teleradiology services
25/03/2019
March 25, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is expanding its radiology solutions portfolio with innovative [...]
Director/PDMR Shareholding
25/03/2019
DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]
FDA clears a new, more rapid treatment protocol for Nexstim's NBT® system when treating patients with major depressive disorder
25/03/2019
Company announcement, Helsinki, 25 March 2019 at 9.00 am (EET) FDA clears a new, more rapid treatment protocol for Nexstim's NBT® system when treating patients with major depressive disorder Nexstim Plc (NXTMH:HEX, [...]
Philips convenes the 2019 Annual General Meeting of Shareholders
25/03/2019
March 25, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today convenes the 2019 Annual General Meeting of Shareholders (AGM) and publishes the agenda with explanatory notes. The agenda includes [...]
PDMR Dealing
25/03/2019
LONDON, March 25, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Oasmia Pharmaceutical AB receives positive opinion from the European Medicines Agency to add efficacy data to the approved Apealea® product information
25/03/2019
Uppsala, Sweden, March 25, 2019 – Oasmia Pharmaceutical AB (NASDAQ: OASM) today announce that the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of a type II variation application [...]
The Alliance for Regenerative Medicine Announces Final Agenda for 2019 Cell & Gene Meeting on the Mediterranean
25/03/2019
The Alliance for Regenerative Medicine Announces Final Agenda for 2019 Cell & Gene Meeting on the Mediterranean WASHINGTON, D.C. – March 25, 2019 The Alliance for Regenerative Medicine (ARM), the international [...]
CLS Presents MRI-Guided, Laser Ablation Solutions for Prostate Cancer at CME-Accredited Conferences in London, Paris & Amsterdam
25/03/2019
More Than 1.3 Million New Cases of Prostate Cancer Worldwide in 2018 LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will be exhibiting and presenting [...]
CLS Presents Studies for Image-Guided Laser, Heat-Induced Cancer Immunotherapy for Tumors at ECIO 2019
25/03/2019
Studies Shared by Physicians from Marseilles Hospital & Portuguese Institute of Oncology LUND, Sweden, March 25, 2019 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced that clinical [...]
Néovacs renforce sa structure financière
25/03/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS RENFORCE SA STRUCTURE FINANCIÈRE: ÉMISSION D'«ORNANE» POUR UN MONTANT MAXIMUM DE €10M, SANS BONS DE SOUSCRIPTION D'ACTIONS Paris et Boston, le [...]
Neovacs reports full-year 2018 Financial results and provides corporate update
25/03/2019
RESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS REPORTS FULL-YEAR 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE KEY OPINION LEADERS VALIDATE THE THERAPEUTIC POTENTIAL OF IFNα KINOID IN LUPUS TREATMENT [...]
Néovacs annonce ses résultats annuels 2018 et fait le point sur ses activités
25/03/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE SES RÉSULTATS ANNUELS 2018 ET FAIT LE POINT SUR SES ACTIVITÉS VALIDATION PAR LES EXPERTS SCIENTIFIQUES DU POTENTIEL THÉRAPEUTIQUE DE L’ [...]
Dermira Announces “Life Unfolds” Direct-to-Consumer Campaign to Highlight QBREXZA™ (glycopyrronium) Cloth
25/03/2019
New multichannel consumer campaign will feature QBREXZA patients Campaign to drive consumer awareness of QBREXZA QBREXZA is the first and only FDA-approved, once-daily, topical prescription treatment indicated for [...]
REVA Receives Interim Funding Commitment and Announces Leadership Changes
25/03/2019
SAN DIEGO, March 24, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that it has secured a letter of commitment for up to $3 million of debt financing to fund operations on an [...]
MediciNova Announces Upcoming Presentations Regarding the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive Multiple Sclerosis at the 71st American Academy of Neurology Annual Meeting in Philadelphia, Pennsylvania
25/03/2019
LA JOLLA, Calif., March 24, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]

Pages